Menu
Not yet recruiting NCT07218835

Compact Auto-Aligning Multi-Modal Eye Imaging to Diagnose Traumatic Eye Injury

— Observational Ocular Pathologies

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Auto-aligning Ocular imaging instrument.
Who it may be relevant to
Registry conditions: Ocular Pathologies. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

Compact Auto-Aligning Multi -Modal Eye Imaging

Overview

The purpose of this study is to test an investigational eye imaging device by taking pictures of participants eyes with a single image capture that takes only seconds.

Interventions

  • Device Auto-aligning Ocular imaging instrument
    Develop a tri-modality, auto-aligning ocular imaging instrument incorporating gross color photography, anterior and posterior segment OCT in a compact, handheld form factor.

Primary outcome measures

  • Number of participants who found the eye imaging device easy to use [Time frame: up to 2 years]
  • Number of participants who found the eye imaging device mobile [Time frame: up to 2 years]
  • Number of participants who found the eye imaging device reliable [Time frame: up to 2 years]
  • Image quality as measured by the number of eye condition diagnoses that match official diagnoses [Time frame: up to 2 years]

Eligibility criteria

Inclusion criteria

  • Ocular complaints potentially indicating anterior segment pathology (e.g., corneal abrasions, corneal edema, corneal scars)
  • Ocular complaints potentially indicating posterior segment pathology (e.g., macular edema, neovascular, macular degeneration)

Exclusion criteria

  • Participant is unable to be imaged for any reason

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Other

Study locations

United States · 1 center
  • Duke Eye Center — Durham

Identifiers

NCT: NCT07218835 · Pro00117676 · HT9425-24-1-0870

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗